Magnetic resonance spectroscopy in the evaluation of central nervous system manifestations of systemic lupus erythematosus

Arthritis Care and Research

Volumn 55, Issue 5, 2006, Pages 807-811

  Appenzeller, Simone ^a   Costallat, Lilian T L ^a   Li, Min ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; AMINE; CREATINE; CREATINE PHOSPHATE; INOSITOL; LACTIC ACID; TETRAMETHYLAMINE DERIVATIVE; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION RESEARCH; HUMAN; INTERMETHOD COMPARISON; NEUROPSYCHIATRY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ASPARTIC ACID; BRAIN; CENTRAL NERVOUS SYSTEM; CREATINE; DISEASE PROGRESSION; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE SPECTROSCOPY; NEURONS;

EID: 33750311760     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22228     Document Type: Review

References (19)

1. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL Jr. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1999;26:81-5.
2. Ackerman JJ, Grove TH, Wong GG, Gadian DG, Radda GK. Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature 1980;283:167-70.
3. De Certaines JD, Bovee WM, Podo F. Magnetic resonance spectroscopy in biology and medicine: functional and pathological tissue characterization. New York: Pergamon Press; 1992.
4. Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 1999;56:919-26.
5. Sibbitt WL Jr, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR Am J Neuroradiol 1994;15:923-8.
6. Appenzeller S, Li LM, Costallat LT, Cendes F. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study. Brain 2005;128:2933-40.
7. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997;18:1271-7.
8. Axford JS, Howe FA, Heron C, Griffiths JR. Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 2001;60:106-11.
9. Handa R, Sahota P, Kumar M, Jagannathan NR, Bal CS, Gulati M, et al. In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). Magn Reson Imaging 2003;21:1033-7.
10. Castellino G, Govoni M, Padovan M, Colamussi P, Borrelli M, Trotta F. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis 2005;64:1022-7.
11. Davie CA, Feinstein A, Kartsounis LD, Barker GJ, McHugh NJ, Walport MJ, et al. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. J Neurol 1995;242:522-8.
12. Friedman SD, Stidley CA, Brooks WM, Hart BL, Sibbitt WL Jr. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998;209:79-84.
13. Lim MK, Suh CH, Kim HJ, Cho YK, Choi SH, Kang JH, et al. Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy. Radiology 2000;217:43-9.
14. Brooks WM, Sabet A, Sibbitt WL Jr, Barker PB, van Zijl PC, Duyn JH, et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997;24:2323-9.
15. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC. Magnetic resonance spectroscopy. J Neuroophthalmol 2005; 25:217-26.
16. Sundgren PC, Jennings J, Attwood JT, Nan B, Gebarski S, McCune WJ, et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005;47:576-85.
17. Kozora E, Arciniegas DB, Filley CM, Ellison MC, West SG, Brown MS, et al. Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol 2005; 18:159-62.
18. Sabet A, Sibbitt WL Jr, Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998;29:2254-60.
19. Chinn RJ, Wilkinson ID, Hall-Craggs MA, Paley MN, Shortall E, Carter S, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:36-46.